An experimental study of efficacy of Shala patra churna in contact poisoning due to Bhallataka taila in albino mice
Keywords:Bhallatak Tail, Semicarpus Anacardium Linn, Poisonous plants, Shala Patra Churna, Contact Poisoning
Bhallataka (Semicarpus Anacaardium Linn. Anacardiaceae) is mentioned as a poisonous medical plant under drug and cosmetic act 1940. Local application of Bhallataka is more common as many people use Bhallataka as home remedy for relieving pain. Bhallataka oil is used commercially in industry for preparation of dyes etc. So, exposure to oil and contact poisoning of Bhallataka is quite common in India. According to Yogaratnakara, Shala Patra Churna, internally & externally application on the whole body immediately relieves the poisonous effect of Bhallataka. Aim: To study efficacy of Shala Patra Churna in contact poisoning due to Bhallataka Taila in Albino mice. Objective: To study antitoxic properties of Shala Patra Churna in contact poisoning due to Bhallataka Taila. Material and methods: Preparation, authentication, and standardization of Bhallatak Tail and Shala Patra Churna. 3 groups were made each of 6 mice. After application procedure, all mice were observed for 24 hours for any signs. Rating of skin reaction was evaluated as per the Indian Standard BIS (Bureau of Indian Standards )1992. Test sample and standard drug applied for 7 consecutive days. Observation and results: Observation done in 3 groups of animals for the duration of 7 days study. All the necessary precautions were taken to carry out each step during study. Conclusion: Effect of local application of Shala patra churna is equivalent to the standard drug (silver nitrate gel). Therefore, Shala plant can be significantly used for the treatment of Bhallataka induced contact poison.
How to Cite
Copyright (c) 2023 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.